Hambleton Julie has filed 8 insider transactions across 2 companies since June 2023.
Most recent transaction: a disposition of 2000 shares of IGM Biosciences, Inc. ($IGMS) on August 14, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | Hambleton Julie | Not found | D | Common Stock | 2000 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 0.00% |
| June 24, 2025 | Erasca, Inc. | $ERAS | Hambleton Julie | Not found | A | Stock option (right to buy) | 120000 | $0.00 | 120,000.0000 | 283,265,716 | 9999.99% | 0.04% |
| July 25, 2024 | IGM Biosciences, Inc. | $IGMS | Hambleton Julie | Not found | S | Common Stock | 15132 | $14.00 | 2,000.0000 | 60,434,161 | 88.33% | 0.03% |
| July 25, 2024 | IGM Biosciences, Inc. | $IGMS | Hambleton Julie | Not found | M | Common Stock | 15132 | $1.39 | 17,132.0000 | 60,434,161 | 756.60% | 0.03% |
| July 25, 2024 | IGM Biosciences, Inc. | $IGMS | Hambleton Julie | Not found | M | Stock Option (right to buy) | 15132 | $0.00 | 0.0000 | 60,434,161 | 100.00% | 0.03% |
| June 20, 2024 | Erasca, Inc. | $ERAS | Hambleton Julie | Director | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Hambleton Julie | Not found | A | Stock Option (right to buy) | 29400 | $0.00 | 29,400.0000 | 52,311,958 | 9999.99% | 0.06% |
| June 22, 2023 | Erasca, Inc. | $ERAS | Hambleton Julie | Director | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |